Pharmacologic Substance
Valganciclovir
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. (NCI04)
Brand Names:
Valcyte
Effect:
Decreased DNA Integrity; Decreased DNA Replication
May Prevent:
Group:
Ganciclovir
Mechanism:
Nucleic Acid Synthesis Inhibitors
More Information:
Medscape
Valcyte (valganciclovir) dosing, indications, interactions, adverse effects, and more.
Viewing results
1 - 10 of 687,000 (0.27 seconds)
-
Oct 15, 2018 ... Valganciclovir may lower the number of red blood cells, white blood cells, and platelets in your body, causing serious and life-threatening ...
-
Mar 5, 2015 ... The treatment of symptomatic congenital cytomegalovirus (CMV) disease with intravenous ganciclovir for 6 weeks has been shown to improve ...
-
Mar 1, 2022 ... Valganciclovir is an antiviral. It is used to treat infections caused by viruses. This medicine is also used to prevent CMV disease in ...
-
Valganciclovir works by slowing the growth of the CMV virus. It helps prevent the spread of infection to other areas of the body.Valganciclovir is also used to ...
-
Valganciclovir is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ...
-
Thirty antiretroviral therapy–treated HIV-infected CMV-seropositive participants with CD4 counts <350 cells/mm3 were randomized to receive valganciclovir ...
-
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
-
May 13, 2009 ... For every 24 patients who receive valganciclovir prophylaxis, one more will develop neutropenia compared to other therapies. The risk of late- ...
-
What is this drug used for? · It is used to treat cytomegalovirus (CMV) infection of the eyes in people with immune system problems. · It is used to prevent ...
-
Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus Disease. David W Kimberlin,.